LPX Lipoxen

TIDMLPX

RNS Number : 7377J

Lipoxen PLC

04 July 2011

 
 For immediate release   4 July 2011 
 

LIPOXEN PLC

Additional listing

Lipoxen plc ("Lipoxen" or "the Company") announces that application has been made to AIM, a market of the London Stock Exchange plc, for the admission of 200,000 ordinary shares of 0.5p each (the "New Ordinary Shares").

The New Ordinary Shares are being admitted pursuant to the exercise of options under the Lipoxen Plc Unapproved Share Option Plan.

It is expected that dealings in the New Ordinary Shares, which will rank pari passu in all respects with the existing issued share capital of the Company, will commence on 5 July 2011.

Enquiries

 
 Lipoxen plc                                       +44 (0)20 7389 5015 
 M. Scott Maguire, Chief Executive 
  Officer 
 
 Singer Capital Markets (nominated 
  adviser)                                         +44 (0)20 3205 7500 
 Jeff Keating / Claes Spang 
 
 Walbrook PR Ltd                                   +44 (0)20 7933 8780 
 Bob Huxford (Media Enquiries)                      Mob: 07747 653 908 
                                            bob.huxford@walbrookpr.com 
 Paul Cornelius (Investor Enquiries)                Mob: 07866 384 707 
                                         paul.cornelius@walbrookir.com 
 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

LISEASXLEELFEFF

Lipoxen (LSE:LPX)
Historical Stock Chart
From Apr 2024 to May 2024

Lipoxen (LSE:LPX)
Historical Stock Chart
From May 2023 to May 2024